Kynam Capital Management, LP Q2 2023 Filing

Filed August 14, 2023

Portfolio Value

$727.1B

Holdings

26

Report Date

Q2 2023

Filing Type

13F-HR

All Holdings (26 positions)

#StockSharesValue% PortfolioType
1
NTRANATERA INC
2,900,000$141K0.00%
2
TCE2CELLDEX THERAPEUTICS INC NEW
2,600,000$88K0.00%
3
ARGXARGENX SE
184,300$71K0.00%Put
4
SNDXSYNDAX PHARMACEUTICALS INC
3,262,004$68K0.00%
5
PCVXVAXCYTE INC
1,300,000$64K0.00%
6
TSVT*2SEVENTY BIO INC
4,890,706$49K0.00%
7
VERAVERA THERAPEUTICS INC
3,000,000$48K0.00%
8
PTGXPROTAGONIST THERAPEUTICS INC
975,298$26K0.00%
9
TVTXTRAVERE THERAPEUTICS INC
1,454,730$22K0.00%
10
BCRXBIOCRYST PHARMACEUTICALS INC
2,848,197$20K0.00%
11
COGTCOGENT BIOSCIENCES INC
1,617,391$19K0.00%
12
BNRBURNING ROCK BIOTECH LTD
8,500,000$18K0.00%
13
VRDNVIRIDIAN THERAPEUTICS INC
709,498$16K0.00%
14
WVEWAVE LIFE SCIENCES LTD
3,924,602$14K0.00%
15
AMRNAMARIN CORP PLC
12,000,000$14K0.00%
16
LQDALIQUIDIA CORPORATION
1,642,244$12K0.00%
17
OLMAOLEMA PHARMACEUTICALS INC
1,304,332$11K0.00%
18
STROSUTRO BIOPHARMA INC
1,500,000$6K0.00%
19
CNTACENTESSA PHARMACEUTICALS PLC
729,077$4K0.00%
20
PTCTPTC THERAPEUTICS INC
28,500$1K0.00%Call
21
PBYIPUMA BIOTECHNOLOGY INC
473,070$1K0.00%
22
RYTMRHYTHM PHARMACEUTICALS INC
92,602$1K0.00%
23
FGENEURFIBROGEN INC
586,500$1K0.00%Call
24
GYRECATALYST BIOSCIENCES INC
89,886$00.00%
25
NEOLEUKIN THERAPEUTICS INC
119,966$00.00%
26
CNTBCONNECT BIOPHARMA HLDGS LTD
535,005$00.00%